US 8222411
Dipeptidyl peptidase inhibitors
granted A61PA61P1/04A61P13/08
Quick answer
US patent 8222411 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/04, A61P13/08, A61P15/08, A61P17/00